trending Market Intelligence /marketintelligence/en/news-insights/trending/lhtwkz__9eohfzotq2hkvg2 content esgSubNav
In This List

Zai Lab prices offering of American depositary shares

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Zai Lab prices offering of American depositary shares

Zai Lab Ltd. priced an underwritten public offering of 7.5 million American depositary shares at $20 each.

Each ADS represents an ordinary share of the Shanghai-based biopharmaceutical company.

Zai Lab expects to raise gross proceeds of about $150 million through the offering, which is expected to close Sept. 10, subject to customary closing conditions.

Underwriters have 30-day option to buy up to an additional 1,125,000 ADSs at the offering price.

J.P. Morgan, Citigroup, Jefferies and Leerink Partners are acting as joint book-running managers for the offering.